See more : Rheinmetall AG (RHM.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Cutera, Inc. (CUTR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cutera, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Success Dragon International Holdings Limited (1182.HK) Income Statement Analysis – Financial Results
- Mory Industries Inc. (5464.T) Income Statement Analysis – Financial Results
- Summi (Group) Holdings Limited (0756.HK) Income Statement Analysis – Financial Results
- Great-West Lifeco Inc (GWLPF) Income Statement Analysis – Financial Results
- Chuanglian Holdings Limited (2371.HK) Income Statement Analysis – Financial Results
Cutera, Inc. (CUTR)
About Cutera, Inc.
Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 212.37M | 252.40M | 231.27M | 147.68M | 181.71M | 162.72M | 151.49M | 118.06M | 94.76M | 78.14M | 74.59M | 77.28M | 60.29M | 53.27M | 53.68M | 83.38M | 101.73M | 100.69M | 75.62M | 52.64M | 39.09M | 28.33M | 19.33M | 9.53M |
Cost of Revenue | 170.88M | 112.57M | 98.17M | 71.91M | 83.55M | 82.34M | 65.38M | 49.92M | 40.48M | 34.77M | 32.71M | 35.74M | 25.98M | 23.06M | 21.76M | 32.36M | 35.00M | 29.86M | 19.79M | 14.69M | 12.32M | 9.99M | 6.94M | 3.37M |
Gross Profit | 41.49M | 139.83M | 133.11M | 75.77M | 98.16M | 80.38M | 86.11M | 68.14M | 54.28M | 43.37M | 41.88M | 41.54M | 34.31M | 30.22M | 31.92M | 51.02M | 66.72M | 70.83M | 55.83M | 37.95M | 26.77M | 18.34M | 12.39M | 6.17M |
Gross Profit Ratio | 19.54% | 55.40% | 57.55% | 51.31% | 54.02% | 49.40% | 56.84% | 57.71% | 57.28% | 55.51% | 56.15% | 53.75% | 56.91% | 56.72% | 59.47% | 61.19% | 65.59% | 70.35% | 73.83% | 72.10% | 68.49% | 64.73% | 64.09% | 64.69% |
Research & Development | 21.41M | 25.16M | 21.57M | 14.32M | 15.09M | 14.36M | 12.87M | 11.23M | 10.73M | 10.54M | 9.22M | 8.43M | 9.14M | 7.00M | 6.81M | 7.55M | 7.17M | 6.47M | 5.07M | 4.14M | 3.45M | 2.99M | 2.11M | 1.54M |
General & Administrative | 63.31M | 45.92M | 32.95M | 31.51M | 24.03M | 21.00M | 14.09M | 12.94M | 12.13M | 11.20M | 9.94M | 11.28M | 10.10M | 9.58M | 10.32M | 46.62M | 50.00M | 48.08M | 32.78M | 27.40M | 18.16M | 5.42M | 0.00 | 989.00K |
Selling & Marketing | 113.00M | 106.95M | 76.76M | 52.77M | 71.11M | 58.42M | 52.07M | 41.56M | 35.94M | 32.25M | 27.98M | 28.66M | 25.50M | 24.74M | 24.29M | 35.35M | 38.28M | 32.89M | 24.80M | 19.05M | 0.00 | 8.60M | 5.43M | 2.79M |
SG&A | 176.32M | 152.86M | 109.71M | 84.28M | 95.14M | 79.42M | 66.16M | 54.51M | 48.07M | 43.45M | 37.92M | 39.94M | 35.60M | 34.31M | 34.61M | 46.62M | 50.00M | 48.08M | 32.78M | 27.40M | 18.16M | 14.02M | 5.43M | 3.78M |
Other Expenses | 0.00 | -3.68M | -2.41M | 68.00K | 0.00 | 0.00 | 0.00 | -7.00K | -37.00K | -180.00K | 34.00K | 16.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.94M | 1.31M | 1.27M | 0.00 | 0.00 | 2.34M | 0.00 |
Operating Expenses | 197.72M | 178.02M | 131.28M | 98.60M | 110.23M | 93.77M | 79.03M | 65.74M | 58.80M | 53.99M | 47.14M | 48.37M | 44.74M | 41.32M | 41.42M | 54.17M | 57.17M | 73.49M | 39.16M | 32.80M | 21.61M | 17.01M | 9.88M | 5.32M |
Cost & Expenses | 368.60M | 290.59M | 229.44M | 170.51M | 193.78M | 176.11M | 144.42M | 115.66M | 99.28M | 88.76M | 79.85M | 84.10M | 70.72M | 64.37M | 63.18M | 86.53M | 92.17M | 103.35M | 58.95M | 47.49M | 33.92M | 27.00M | 16.82M | 8.69M |
Interest Income | 9.19M | 2.60M | 3.79M | 647.00K | 0.00 | 123.00K | 884.00K | 323.00K | 330.00K | 406.00K | 421.00K | 481.00K | 594.00K | 539.00K | 0.00 | 3.05M | 4.21M | 3.60M | 2.03M | 632.00K | 30.00K | 85.00K | 171.00K | 193.00K |
Interest Expense | 14.02M | 5.66M | 2.51M | 579.00K | 199.00K | 884.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 8.58M | 8.47M | 5.49M | 6.51M | 4.46M | 3.04M | 1.02M | 982.00K | 1.19M | 1.34M | 1.30M | 1.61M | 637.00K | 717.00K | 860.00K | 904.00K | 913.00K | 869.00K | 689.00K | 1.96M | 443.00K | 382.00K | 0.00 | 0.00 |
EBITDA | -140.94M | -65.22M | 58.00K | -16.90M | -10.52M | -12.18M | 8.09M | 3.38M | -3.34M | -9.06M | -3.95M | -4.72M | -9.80M | -10.38M | -7.91M | -2.25M | 10.47M | -2.66M | 17.98M | 5.15M | 5.61M | 1.71M | 2.51M | 844.00K |
EBITDA Ratio | -66.37% | -15.06% | 0.03% | -14.51% | -5.79% | -7.49% | 2.70% | 2.86% | -3.52% | -11.88% | -5.30% | -6.76% | -16.28% | -19.49% | -14.50% | 1.57% | 10.29% | 17.03% | 23.78% | 13.51% | 14.34% | 6.04% | 12.99% | 8.86% |
Operating Income | -156.23M | -38.19M | -1.29M | -22.83M | -12.06M | -13.39M | 11.08M | 2.40M | -4.52M | -10.62M | -5.26M | -6.83M | -10.43M | -11.10M | -10.34M | -3.15M | 9.56M | -2.66M | 16.67M | 5.15M | 5.16M | 1.33M | 2.51M | 844.00K |
Operating Income Ratio | -73.57% | -15.13% | -0.56% | -15.46% | -6.64% | -8.23% | 7.31% | 2.03% | -4.77% | -13.59% | -7.05% | -8.83% | -17.30% | -20.83% | -19.27% | -3.78% | 9.39% | -2.64% | 22.05% | 9.79% | 13.21% | 4.70% | 12.99% | 8.86% |
Total Other Income/Expenses | -5.07M | -42.51M | 1.56M | -579.00K | -199.00K | -123.00K | 884.00K | 323.00K | 293.00K | 226.00K | 455.00K | 497.00K | 614.00K | 583.00K | 1.57M | -508.00K | 4.21M | 3.60M | 2.03M | 632.00K | 30.00K | 85.00K | 171.00K | 193.00K |
Income Before Tax | -161.30M | -80.70M | 3.39M | -23.41M | -12.26M | -13.52M | 11.96M | 2.72M | -4.23M | -10.39M | -4.80M | -6.33M | -9.82M | -10.52M | -8.77M | -3.66M | 13.76M | 939.00K | 18.71M | 5.79M | 5.19M | 1.42M | 2.68M | 1.04M |
Income Before Tax Ratio | -75.95% | -31.97% | 1.46% | -15.85% | -6.75% | -8.31% | 7.89% | 2.30% | -4.46% | -13.30% | -6.44% | -8.19% | -16.28% | -19.74% | -16.34% | -4.39% | 13.53% | 0.93% | 24.74% | 10.99% | 13.29% | 5.00% | 13.87% | 10.88% |
Income Tax Expense | 1.53M | 1.64M | 1.32M | 470.00K | 85.00K | 17.26M | -18.03M | 143.00K | 212.00K | 219.00K | -54.00K | 218.00K | 243.00K | 2.00K | 8.91M | -792.00K | 3.26M | -1.18M | 4.91M | 2.03M | 2.09M | 755.00K | 342.00K | 0.00 |
Net Income | -162.83M | -82.34M | 2.06M | -23.88M | -12.35M | -30.77M | 29.99M | 2.58M | -4.44M | -10.61M | -4.75M | -6.55M | -10.06M | -10.52M | -17.68M | -2.87M | 10.50M | 2.12M | 13.80M | 3.76M | 3.11M | 660.00K | 2.34M | 1.04M |
Net Income Ratio | -76.67% | -32.62% | 0.89% | -16.17% | -6.80% | -18.91% | 19.80% | 2.18% | -4.69% | -13.58% | -6.36% | -8.47% | -16.69% | -19.74% | -32.93% | -3.44% | 10.33% | 2.11% | 18.25% | 7.14% | 7.95% | 2.33% | 12.10% | 10.88% |
EPS | -8.19 | -4.39 | 0.12 | -1.43 | -0.88 | -2.23 | 2.16 | 0.19 | -0.32 | -0.74 | -0.33 | -0.46 | -0.73 | -0.78 | -1.33 | -0.22 | 0.80 | 0.17 | 1.20 | 0.38 | 1.47 | 0.36 | 0.38 | 0.18 |
EPS Diluted | -8.19 | -4.39 | 0.11 | -1.43 | -0.88 | -2.23 | 2.04 | 0.19 | -0.32 | -0.74 | -0.33 | -0.46 | -0.73 | -0.78 | -1.33 | -0.22 | 0.74 | 0.15 | 1.00 | 0.31 | 0.35 | 0.07 | 0.27 | 0.13 |
Weighted Avg Shares Out | 19.89M | 18.75M | 17.89M | 16.69M | 14.10M | 13.77M | 13.87M | 13.23M | 13.88M | 14.25M | 14.42M | 14.09M | 13.81M | 13.54M | 13.28M | 12.77M | 13.15M | 12.56M | 11.54M | 8.57M | 2.11M | 1.81M | 1.48M | 1.06M |
Weighted Avg Shares Out (Dil) | 19.89M | 18.75M | 18.36M | 16.69M | 14.10M | 13.77M | 14.73M | 13.75M | 13.96M | 14.25M | 14.42M | 14.09M | 13.81M | 13.54M | 13.28M | 12.77M | 14.23M | 14.28M | 13.86M | 12.22M | 8.84M | 8.81M | 8.73M | 8.01M |
CUTR DEADLINE TODAY: ROSEN, A LEADING NATIONAL FIRM, Encourages Cutera, Inc. Investors to Secure Counsel Before Important July 24 Deadline in Securities Class Action – CUTR
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Cutera Investors of a Lead Plaintiff Deadline of July 24, 2023
CUTR MONDAY DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Cutera, Inc. Investors to Secure Counsel Before Important July 24 Deadline in Securities Class Action - CUTR
Cutera, Inc. to Announce Second Quarter Results on August 8, 2023
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cutera, Inc. (CUTR)
CUTR SHAREHOLDER ALERT: Jakubowitz Law Reminds Cutera Shareholders of a Lead Plaintiff Deadline of July 24, 2023
CUTR Investors Have Opportunity to Lead Cutera, Inc. Securities Fraud Lawsuit
CUTR LAWSUIT ALERT: Levi & Korsinsky Notifies Cutera, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Cutera, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 24, 2023 - (NASDAQ: CUTR)
CUTR ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 24, 2023 in the Class Action Filed on Behalf of Cutera, Inc. Shareholders
Source: https://incomestatements.info
Category: Stock Reports